Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
AEZS-134
i
Other names:
AEZS-134
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
AEterna Zentaris
Drug class:
ERK inhibitor
Related drugs:
‹
SCH772984 (11)
ONC201 (5)
KO-947 (3)
DEL-22379 (2)
AEZS-129 (1)
CC-90003 (0)
bezisterim (0)
NSC311152 (0)
RG7842 (0)
SCH772984 (11)
ONC201 (5)
KO-947 (3)
DEL-22379 (2)
AEZS-129 (1)
CC-90003 (0)
bezisterim (0)
NSC311152 (0)
RG7842 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
GNRHR expression
Triple Negative Breast Cancer
GNRHR expression
Triple Negative Breast Cancer
triptorelin + AEZS 136 + AEZS-134
Sensitive: D – Preclinical
triptorelin + AEZS 136 + AEZS-134
Sensitive
:
D
triptorelin + AEZS 136 + AEZS-134
Sensitive: D – Preclinical
triptorelin + AEZS 136 + AEZS-134
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login